Chemoinformaics analysis of (E)-Hexadec-11-enal
| Molecular Weight | 238.415 | nRot | 13 |
| Heavy Atom Molecular Weight | 208.175 | nRig | 2 |
| Exact Molecular Weight | 238.23 | nRing | 0 |
| Solubility: LogS | -4.969 | nHRing | 0 |
| Solubility: LogP | 5.693 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 47 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 47.5258 |
| nHD | 0 | BPOL | 30.9642 |
| QED | 0.237 |
| Synth | 2.275 |
| Natural Product Likeliness | 1.251 |
| NR-PPAR-gamma | 0.49 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.011 |
| Pgp-sub | 0.001 |
| HIA | 0.009 |
| CACO-2 | -4.786 |
| MDCK | 0.0000194 |
| BBB | 0.728 |
| PPB | 0.951849 |
| VDSS | 4.352 |
| FU | 0.0122042 |
| CYP1A2-inh | 0.432 |
| CYP1A2-sub | 0.206 |
| CYP2c19-inh | 0.432 |
| CYP2c19-sub | 0.066 |
| CYP2c9-inh | 0.263 |
| CYP2c9-sub | 0.954 |
| CYP2d6-inh | 0.471 |
| CYP2d6-sub | 0.41 |
| CYP3a4-inh | 0.375 |
| CYP3a4-sub | 0.052 |
| CL | 2.963 |
| T12 | 0.477 |
| hERG | 0.263 |
| Ames | 0.008 |
| ROA | 0.01 |
| SkinSen | 0.976 |
| Carcinogencity | 0.103 |
| EI | 0.941 |
| Respiratory | 0.947 |
| NR-Aromatase | 0.148 |
| Antiviral | Yes |
| Prediction | 0.743527 |